AstraZeneca PLC operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares AstraZeneca PLC with three other
pharmaceutical manufacturers in Europe:
Novo Nordisk As
sales of 111.78 billion Danish Kroner [US$17.37 billion]
of which 80%
was Diabetes Care),
(15.02 billion Euro [US$17.35 billion]
of which 46%
was Healthcare), and
(£8.48 billion [US$11.05 billion]
of which 100%
was Pharmaceuticals & Genetic Therapies).
During the year ended December of 2016, sales at
AstraZeneca PLC were £17.11 billion (US$22.31 billion).
increase of 5.6%
versus 2015, when the company's sales were £16.20 billion.